Form 4: Zomedica CEO Larry Heaton II Acquires and Disposes of Shares in Recent Transaction
SEC Form 4
Zomedica Corp. CEO Larry Heaton II reports acquiring 100,000 shares and disposing of 300,000 shares of common stock on May 13, 2024.
Summary
- On May 13, 2024, Larry Heaton II, CEO of Zomedica Corp., engaged in transactions involving the company's common stock.
- He acquired 100,000 shares at a price of $0.142 per share.
- Simultaneously, he disposed of 300,000 shares.
- Following these transactions, the reporting person still beneficially owns securities.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it simply reports transactions without indicating positive or negative implications for the company.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC when company insiders, like the CEO, trade in their company's stock. It provides transparency to the market about the transactions of those with privileged information.
Stakeholder Impact
- The transactions may influence investor sentiment regarding the company's prospects.
Key Dates
| Date | Description |
|---|---|
| 05/13/2024 | Date of stock acquisition and disposition by Larry Heaton II |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.